November 1, 2022
FDA: Five companies are having amoxicillin shortages
Editor's Note
As of November 1, the Food and Drug Administration (FDA) listed 26 amoxicillin products on its current drug shortages site. The FDA says increased demand is the largest cause of the shortage.
The FDA does not list resupply dates, but the American Society of Health-System Pharmacists (ASHP) estimates resupply dates for Hikma products (August 2023), Sandoz products (cannot estimate a release date), and Teva products (November and December 2022).
Free Daily News
- Study: Long working hours alter brain regions tied to emotion, cognition
- Survey: Burnout, rigid schedules push nurses to leave
- UCLA surgeons perform world’s first bladder transplant
- AHA urges HHS to cut regulations that burden hospitals and staff
- Commentary: Overlooking, underfunding perioperative mental health threatens patients
- Study: Fewer men undergo unnecessary prostate cancer surgery amid rise in active surveillance
- OpenAI benchmarking tool tests healthcare LLMs
- Healthgrades recognizes top 15% of hospitals for patient experience in 2025
- Q1 reports show climb in outpatient surgical volume, diverging trends at Surgery Partners, Ardent Health
- Study: SGLT2 inhibitors raise postop euglycemic ketoacidosis risk but lower mortality
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement